melanocortin analogue raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2026-02-10. Anything still debated is marked as such rather than presented as settled.
The molecular backbone consists of seven amino acid residues joined into a ring through a disulfide bridge. This cyclic conformation is critical for receptor binding. The sequence includes an acetylated N-terminus and an amidated C-terminus, modifications that improve resistance to enzymatic breakdown. One residue is in the D-configuration, a feature that further stabilizes the peptide against protease activity. Together, the ring structure and specific stereochemistry determine selectivity among melanocortin receptor subtypes.
Across literature and commercial listings, the substance appears under several names, including bremelanotide, PT-141, and various brand designations. A CAS registry number provides a unique identifier for the compound, aiding retrieval from chemical databases. Synonym lists may also contain early development codes and descriptive chemical names. When consulting sources, researchers need to confirm that the cited names refer to the same molecular structure to avoid confusion. Naming consistency matters especially when comparing analytical data across publications.
Published discussion sits at the intersection of peptide chemistry, neuroendocrinology and sexual medicine. Trial reports emphasise change scores on validated instruments, while mechanistic papers focus on hypothalamic circuits and receptor selectivity. Because placebo response in this field is large, effect sizes are usually reported with confidence intervals rather than as isolated averages. Reviews note that female and male data sets are not interchangeable and should be read separately. Diagnostic terminology has been revised over time, which complicates comparison between older and newer studies.
Bremelanotide is a synthetic cyclic heptapeptide that acts on a family of G-protein-coupled receptors. It was designed as a structural analogue of alpha-melanocyte-stimulating hormone, the endogenous peptide associated with pigmentation and several central signalling pathways. A lactam bridge constrains the ring and slows enzymatic breakdown, which distinguishes it from the linear parent molecule. Research interest moved over time from pigment biology toward central nervous system effects, particularly circuits connected to sexual desire. Parenteral delivery is used because oral bioavailability is poor.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Cyclic peptide | Melanocortin receptor agonist family |
| Molecular weight | Approximately 1025 Da | Free base form |
| Appearance | White to off-white powder | Lyophilized product |
| Solubility | Soluble in water | Also dissolves in polar organic solvents |
| Storage temperature | -20 degrees Celsius | Dry and protected from light |
Approved use is narrow and jurisdiction-specific. In the United States, the injectable product is authorised for premenopausal women with acquired, generalised hypoactive sexual desire disorder, a diagnosis that requires documented distress. It is not approved for men, for postmenopausal women, or for use alongside hormonal contraceptives under the approved labelling. Outside regulated markets, the same peptide is frequently sold as a research chemical, where identity, purity, and sterility are not independently verified.
Bremelanotide is a synthetic cyclic heptapeptide developed as an analogue of alpha-melanocyte-stimulating hormone, a naturally occurring peptide involved in pigmentation and appetite signalling. Its structure contains seven amino acid residues joined by a lactam bridge that closes the ring between two side chains. The molecular formula is C50H68N14O10 and the nominal molecular mass is near 1025 daltons. Much of the early laboratory literature refers to the same molecule by the development code PT-141.
Development of the peptide passed through several delivery formats, including an intranasal version tested in early trials and an injectable version that entered later clinical study. Regulatory approval for a subcutaneous product in the United States was granted in 2019 after review of controlled trials in premenopausal women. Outside the clinic, the compound circulates in research and non-pharmaceutical markets under its code name, where identity and purity vary considerably between suppliers. Synonyms appearing across technical literature include bremelanotide, PT-141, and Palatin 141.
PT-141 is the research designation for bremelanotide, a synthetic cyclic heptapeptide developed as a melanocortin receptor agonist. The peptide contains seven amino acids with an internal lactam bridge that constrains the backbone into a stable ring. Cyclisation of this kind improves resistance to enzymatic degradation relative to linear analogues. The compound was first explored for effects on melanin production, because several melanocortin receptors influence pigmentation. Its later association with sexual desire emerged from observations made during that early work, and the molecule became the subject of a separate development programme.
Bremelanotide is a moderately large peptide with a molecular mass near 1025 daltons. In lyophilised form it appears as a white to off-white powder and is freely soluble in water and other polar solvents. The intact lactam ring is essential for receptor affinity, while linearised fragments bind far more weakly. Solutions are sensitive to extremes of pH and to prolonged exposure to light and heat, so handling typically involves buffered conditions and cold storage. Its short plasma half-life reflects rapid distribution and clearance rather than chemical breakdown inside the vial.
Clinical development of bremelanotide proceeded through several reformulation attempts. An early intranasal version was discontinued, and a subcutaneous auto-injector formulation later received approval for hypoactive sexual desire disorder in premenopausal women. Approval decisions have varied by country and over time, and the product has not been universally adopted. Blood pressure elevation is a documented effect, which is why some jurisdictions require monitoring after administration. The clinical evidence base continues to evolve as additional studies are published.
Bremelanotide is a cyclic heptapeptide that acts as an agonist at melanocortin receptors. It binds MC1R, MC3R, MC4R, and MC5R, with MC4R activation considered most relevant to sexual desire pathways in the central nervous system. The molecule is a synthetic analog of alpha-melanocyte-stimulating hormone, a naturally occurring peptide involved in pigmentation and energy regulation. Early research explored its use in tanning before attention shifted toward sexual dysfunction applications. Receptor binding affinity varies across these subtypes.
Activation of MC4R in the hypothalamus is thought to influence dopaminergic signaling, which in turn affects arousal and desire. This mechanism differs from that of phosphodiesterase type 5 inhibitors, which act primarily on vascular smooth muscle in the genital region. Because the pathway is central rather than peripheral, effects are not strictly dependent on local blood flow. The precise downstream cascade linking receptor binding to behavioral outcomes remains an area of ongoing investigation.
== Epidemiology == Cholecystitis accounts for 3–10% of cases of abdominal pain worldwide. Cholecystitis caused an estimated 651,829 emergency department visits and 389,180 hospital admissions in the US in 2012. The 2012 US mortality rate was 0.7 per 100,000 people. The frequency of cholecystitis is highest in people age 50–69 years old.
== Matrices and sample introduction == As previously stated, in FAB the samples are mixed with a non-volatile environment (matrix) in order to be analyzed. FAB uses a liquid matrix that is mixed with the sample in order to provide a sample ion current that is sustained, reduces damages made to the sample by absorbing the impact of the primary beam, and keeps the sample molecules form aggregating. The liquid matrix, like any other matrix, most importantly provides a medium that promotes sample ionization. The most widely accepted matrix for this type of ionization is glycerol. Choosing the appropriate matrix for the sample is crucial because the matrix can also influence the degree of fragmentation of the sample (analyte) ions. The sample can then be introduced to FAB analysis. The normal method of introducing the sample-matrix mixture is through an insertion probe. The sample-matrix mixture is loaded on a stainless steel sample target on the probe, which is then placed in the ion source via a vacuum lock. The alternative method of introducing the sample is by using a device called continuous flow fast atom bombardment (CF)-FAB.
Commission D2: Refrigerated Transport The IIR's Commission D2 on Refrigerated Transport is extremely active. In addition to the IIR's four-yearly congress, Commission D2 participates in the IIR Conference on Sustainability and the Cold Chain, held out of synchronisation with the congress. Every year, Commission D2 CERTE test engineers meet in a European country to discuss refrigerated transport technology and testing issues. This group subsequently advises the United Nations working party on transport of perishable foodstuffs held each year in Geneva. Commission D2 is currently addressing the “Cold Chain for Pharmaceutical Products” and will add this to regular transport discussion and advisory topics. Commission D2 also helps to produce Informatory Notes to assist in areas of technical or regulatory difficulty. The IIR is recognised, for its contributions to refrigerated transport, particularly through the work of its Commission D2. The commission's research addresses food waste reduction and emissions mitigation.
Furikake (振り掛け, ふりかけ, 振掛け, 振掛) is a dry Japanese condiment sprinkled on top of cooked rice, or used as an ingredient in onigiri. It typically consists of a mixture of dried fish or freeze-dried eggs, sesame seeds, dried seaweed flakes, sugar, and salt. Other ingredients, such as katsuobushi (sometimes indicated on the package as bonito), okaka (bonito flakes moistened with soy sauce and dried again), freeze-dried salmon particles, shiso, egg, powdered miso, or vegetables, are often added. Furikake is often brightly colored and flaky. It can have a slight fish or seafood flavoring and may be spicy or sweet. It can be used in Japanese cooking for pickling and for rice balls (onigiri).
After the first two days the insurgents lost their offensive initiative, and the combined South African forces drove PLAN back across the border in a counteroffensive codenamed Operation Merlyn. Between 1 and 9 April 1989, 273 PLAN insurgents were killed in the fighting. The SADF and police suffered 23 dead. On 8 April 1989, the JMMC issued the Mount Etjo Declaration, which reiterated that the Tripartite Accord was still in effect and that South Africa, Angola, and Cuba remained committed to peace. It also ordered all PLAN insurgents remaining in Ovamboland to surrender at UNTAG-supervised assembly points. Sam Nujoma denied any incursion had taken place on 1 April, claiming that he had only ordered PLAN insurgents already inside South West Africa to begin establishing base camps. He also pointed out that SWAPO had never been a signatory to the Tripartite Accord, and therefore the cessation of hostilities as dictated by its terms was non-binding. This drew some ire from Angola, which had given guarantees to the UN that PLAN would remain north of the 16th parallel. The SADF was re-confined to its bases on 26 April, then released into Ovamboland again to verify that the insurgents had departed. By May, all but a small handful of PLAN insurgents had been relocated north of the 16th parallel under JMMC supervision, effectively ending the South African Border War. General elections under a universal franchise were held in South West Africa between 7 and 11 November 1989, returning 57% of the popular vote for SWAPO.
Sources: en.wikipedia.org
In some cases vaccines may result in partial immune protection (in which immunity is less than 100% effective but still reduces risk of infection) or in temporary immune protection (in which immunity wanes over time) rather than full or permanent immunity. They can still raise the reinfection threshold for the population as a whole and make a substantial impact. They can also mitigate the severity of infection, resulting in a lower mortality rate, lower morbidity, faster recovery from illness, and a wide range of other effects. Those who are older often display less of a response than those who are younger, a pattern known as Immunosenescence. Adjuvants commonly are used to boost immune response, particularly for older people whose immune response to a simple vaccine may have weakened. The efficacy or performance of the vaccine is dependent on several factors:
Extracellular polymeric substances (EPS) are natural polymers of high molecular weight secreted by microorganisms into their environment. EPS establish the functional and structural integrity of biofilms, and are considered the fundamental component that determines the physicochemical properties of a biofilm. EPS in the matrix of biofilms provides compositional support and protection of microbial communities from the harsh environments. Components of EPS can be of different classes of polysaccharides, lipids, nucleic acids, proteins, lipopolysaccharides, and minerals.
First, it had several interesting things happen in it, all triggered by the player rather than a timer so that the player would set the pace of the level. Second, the level responded to any player action, even for something as simple as adding graphic decals to wall textures to show a bullet impact. Finally, the level warned the player of imminent danger to allow them to avoid it, rather than killing the player with no warning. To move forward with this unified design, Valve sought a game designer but found no one suitable. Instead, Valve created the "cabal", initially a group of six individuals from across all departments that worked primarily for six months straight in six-hour meetings four days a week. The cabal was responsible for all elements of design, including level layouts, key events, enemy designs, narrative, and the introduction of gameplay elements relative to the story. The collaboration proved successful, and once the cabal had come to decisions on types of gameplay elements that would be needed, mini-cabals from other departments most affected by the choice were formed to implement these elements. Membership in the main cabal rotated since the required commitment created burnout.
It is also known that hypothalamic–pituitary–adrenal axis (HPA) hormones are related to certain skin diseases and skin homeostasis. There is evidence linking hyperactivity of HPA hormones to stress-related skin diseases and skin tumors.
=== Secondary literature === Johns, Michael (5 November 1989). "Namibian Voters Deny Total Power to SWAPO. [Reprint]". barrysgovsites.blogspot.com. The Wall Street Journal, original publisher. Retrieved 7 November 2024. van der Hoog, Tycho (June 2022). "A New Chapter in Namibian History: Reflections on Archival Research". History in Africa. 49. Cambridge University Press: 389–414. doi:10.1017/hia.2021.12. hdl:1887/3303534. Retrieved 7 November 2024. An explainer of existing archives on SWAPO.
Sources: en.wikipedia.org
=== Transport Reaction === The generalized transport reaction catalyzed by members of the CPA2 family is:M+ (in) + nH+ (out) ⇌ M+ (out) + nH+ (in).(The carrier-mediated mode)Some members may also catalyze:M+ (in) ⇌ M+ (out).(The channel-mediated mode)
TabA (P31851), an enzyme related to lysA (diaminopimelate decarboxylase) TabB (P31852), an enzyme related to dapD (THDPA succinyl-CoA succinyltransferase, THDPA-ST) TblA (P31850), an enzyme with no close paralogs (identified as a member of SAMe-dependent methyltransferase superfamily by InterPro) This pathway produces TBL; the enzyme TblF finalize the synthesis by linking TBL to Thr to form tabtoxin.
== Other projects == Staley shared lead vocals with Ann Wilson for a cover of Bob Dylan's "Ring Them Bells", featured on Heart's 1993 album Desire Walks On. The song "It's Coming After" from Second Coming's 1994 debut album L.O.V.Evil features Staley on lead vocals. Second Coming features Staley's bandmates from Alice N' Chains, his former band. One of the last songs that Staley recorded was a cover of Pink Floyd's "Another Brick in the Wall" with the supergroup Class of '99, featuring guitarist Tom Morello of Rage Against the Machine, bassist Martyn LeNoble, drummer Stephen Perkins, both from Jane's Addiction and Porno for Pyros, and keyboardist Matt Serletic. In November 1998, the group recorded the song for Robert Rodriguez's 1998 horror/sci-fi film The Faculty. A music video was also released. While the other members of the band were filmed specifically for the video, Staley's appearance consisted of footage pulled from Mad Season's 1995 Live at the Moore video. A song titled "Things You Do" featuring Staley on vocals was part of the soundtrack to the 2012 film Grassroots. In the film, the song was credited to "The Bondage Boys featuring Layne Staley", but the song had been credited to "Layne Staley and The Aftervibes" and "Layne Staley and Second Coming" when it leaked on the internet years before.
In the 1960s, the modern version of granola was invented and popularized. It evolved from a product called Granula (similar to Grape Nuts) to the recognizable modern form involving at a minimum: sweetened toasted oats, but also possibly: dried fruit, puffed rice, nuts or chocolate.
=== Discrimination === In March 2021, Eli Lilly and Company was accused of sex discrimination by a former lobbyist who claimed she was forced to work in a sexually hostile work environment. The parties involved settled for an undisclosed amount in June 2021. In September 2021, Eli Lilly and Company was accused in a federal court lawsuit of discriminating against older applicants for sales positions based on their implementation of hiring quotas for millennials.
Sources: en.wikipedia.org
It belongs to the melanocortin receptor agonist family of peptides. Its cyclic structure distinguishes it from linear peptides and shapes its receptor binding profile.
It emerged from research on melanotan II. Investigators exploring derivatives observed distinct pharmacological features related to sexual function.
Common names include bremelanotide and PT-141. Chemical databases may also list early development codes and descriptive names.
It is a synthetic cyclic peptide that activates melanocortin receptors. It is given by injection and was approved in the United States in 2019 for a specific low-desire diagnosis in premenopausal women. It is not a hormonal therapy.